Results 151 to 160 of about 10,033 (195)

Recurrent Eosinophilic Fasciitis: The First Case Report. [PDF]

Clin Cosmet Investig Dermatol
Ge G, Su F, Chen H, Hu B, Chen J.
europepmc   +1 more source

Superb microvascular imaging for evaluating the activity of juvenile localised scleroderma: a preliminary study. [PDF]

Eur Radiol
Chen X, Zhou L, Xia Y, Wong YN, He Q, Tang P, Zhang S, Liu T, Wang Z, Xu N.   +9 more
europepmc   +1 more source

Undercover lung damage in pediatrics - a hot spot in morbidity caused by collagenoses. [PDF]

Front Immunol
Lupu A, Sasaran MO, Jechel E, Azoicai A, Alexoae MM, Starcea IM, Mocanu A, Nedelcu AH, Knieling A, Salaru DL, Burlea SL, Lupu VV, Ioniuc I.   +12 more
europepmc   +1 more source

Case report: anti-fibrillarin autoantibodies induced by viral molecular mimicry in a paediatric patient. [PDF]

Ital J Pediatr
Autilio C, Pecoraro R, Pafundi V, Manieri S, Tipo V, Martemucci L, Carbone T.   +6 more
europepmc   +1 more source

Innovations in immunotherapy for autoimmune diseases: recent breakthroughs and future directions. [PDF]

Front Immunol
Alsayb MA.
europepmc   +1 more source

Use of Glucagon-Like Peptide-1 (GLP-1) Agonists in Modulating Preexisting Dermatologic Disease: A Systematic Review. [PDF]

Cureus
Tassavor B, Al Salem S.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Systemic therapy in juvenile localized scleroderma

Expert Review of Clinical Immunology, 2023
Introduction Juvenile localized scleroderma (JLS) is a rare sclerosing disorder of childhood which can result in permanent morbidity and functional disability, if not effectively treated.
I. Foeldvari, E. Marrani
semanticscholar   +3 more sources

Predictors of family impact of juvenile localized scleroderma

Pediatric Dermatology, 2021
To measure the impact juvenile localized scleroderma (jLS) has on family quality of life and to identify predictors of family impact in this population which may inform the development of tailored resources to enhance family functioning for patients with
Katia Milovanova, Merna Adly, B. Lethebe, R. Stevenson, V. Prajapati, Nadia J C Luca   +5 more
semanticscholar   +3 more sources

Juvenile localized scleroderma: A single‐centre experience from India

Journal of the European Academy of Dermatology and Venereology, 2022
Juvenile localized scleroderma (JLS) or morphoea, a rare chronic autoimmune disease predominantly affects skin, subcutaneous tissue and occasionally the adjacent muscle, fascia and bone.
A. Jindal, S. Handa, S. Loganathan, Murugan Sudhakar, A. Kaushik, D. Suri, V. Pandiarajan, A. Rawat, Anju Gupta, D. De, R. Mahajan, Surjit Singh   +11 more
semanticscholar   +3 more sources